Allergan Competitors and Similar CompaniesClear all

Allergan's competitors and similar companies include Alcon, Genentech and Teva Pharmaceuticals.

	Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products.	Alcon Alcon is a company that manufactures surgical and vision care products.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Teva Pharmaceuticals Teva Pharmaceuticals is a global pharmaceutical company.
Founding Date	Founding Date 1948	Founding Date 1945	Founding Date 1976	Founding Date 1901
Type	Type Subsidiary	Type Public	Type Subsidiary	Type Public
Tags	Tags Healthcare drug development medical devices pharma	Tags Healthcare eyewear medical devices optics pharmacy	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare drug development pharma therapy
Locations	Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more	Locations Geneva, CH HQ Macquarie Park, AU Wien, AT Mechelen, BE Mississauga, CA Beijing, CN Praha, CZ see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more
Employees	Employees 10,5471% decrease	Employees 25,000	Employees 18,077	Employees 37,000
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $10.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $17.3b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $3.4b (FY, 2025)	Cost of goods N/A	Cost of goods $8.3b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $7.2b (FY, 2025)	Gross profit N/A	Gross profit $8.9b (FY, 2025)
Net income	Net income N/A	Net income $980m (FY, 2025)	Net income N/A	Net income $1.4b (FY, 2025)
Operating ⚠
Countries	Countries 100 (Q1, 2020)	Countries 60 (Sep, 2022)	Countries N/A	Countries N/A
Facilities	Facilities 21 (FY, 2019)	Facilities N/A	Facilities N/A	Facilities 90 (FY, 2019)